Vincent Angotti
Chief Executive Officer bei TALPHERA, INC.
Vermögen: 175 930 $ am 31.03.2024
Profil
Vincent J.
Angotti is currently the Chief Executive Officer & Director at Talphera, Inc. He previously served as the Chief Executive Officer at XenoPort, Inc. from 2008 to 2016.
Prior to that, he held the position of Executive Director-Field Operations at Novartis Pharmaceuticals Corp.
from 1991 to 2001.
He also worked as the Senior Vice President-Sales & Marketing at Reliant Pharmaceuticals LLC from 2001 to 2008.
Mr. Angotti holds an MBA from The Trustees of Columbia University in The City of New York, which he obtained in 2000.
He completed his undergraduate degree at Cornell University in 1990.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TALPHERA, INC.
1,01% | 12.03.2024 | 170 806 ( 1,01% ) | 175 930 $ | 31.03.2024 |
Aktive Positionen von Vincent Angotti
| Unternehmen | Position | Beginn |
|---|---|---|
| TALPHERA, INC. | Chief Executive Officer | 06.03.2017 |
Ehemalige bekannte Positionen von Vincent Angotti
| Unternehmen | Position | Ende |
|---|---|---|
| XENOPORT, INC. | Chief Executive Officer | 01.07.2016 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Sales & Marketing | 01.01.2008 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Vincent Angotti
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Cornell University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TALPHERA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
